Suppr超能文献

从用于血流感染诊断的原代液体血液培养物中提取DNA,采用全基因组测序技术。

DNA extraction from primary liquid blood cultures for bloodstream infection diagnosis using whole genome sequencing.

作者信息

Anson Luke W, Chau Kevin, Sanderson Nicholas, Hoosdally Sarah, Bradley Phelim, Iqbal Zamin, Phan Hang, Foster Dona, Oakley Sarah, Morgan Marcus, Peto Tim E A, Crook Derrick W, Pankhurst Louise J

机构信息

Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK.

Present address: Genomic Research Laboratory, Division of Infectious Diseases, University of Geneva Hospitals, Rue Gabrielle-Perret-Gentil, 4, CH-1211 Geneva 14, Switzerland.

出版信息

J Med Microbiol. 2018 Mar;67(3):347-357. doi: 10.1099/jmm.0.000664. Epub 2018 Jan 10.

Abstract

PURPOSE

Speed of bloodstream infection diagnosis is vital to reduce morbidity and mortality. Whole genome sequencing (WGS) performed directly from liquid blood culture could provide single-assay species and antibiotic susceptibility prediction; however, high inhibitor and human cell/DNA concentrations limit pathogen recovery. We develop a method for the preparation of bacterial DNA for WGS-based diagnostics direct from liquid blood culture.

METHODOLOGY

We evaluate three commercial DNA extraction kits: BiOstic Bacteraemia, Amplex Hyplex and MolYsis Plus. Differential centrifugation, filtration, selective lysis and solid-phase reversible immobilization bead clean-up are tested to improve human cells/DNA and inhibitor removal. Using WGS (Illumina/MinION), we assess human DNA removal, pathogen recovery, and predict species and antibiotic susceptibility inpositive blood cultures of 44 Gram-negative and 54 Staphylococcus species.Results/Key findings. BiOstic kit extractions yield the greatest mean DNA concentration, 94-301 ng µl, versus 0-2.5 ng µl using Amplex and MolYsis kits. However, we note higher levels of inhibition (260/280 ratio 0.9-2.1) and human DNA (0.0-4.4×10 copies) in BiOstic extracts. Differential centrifugation (2000 g, 1 min) prior to BiOstic extraction reduces human DNA by 63-89 % with selective lysis minimizing by a further 62 %. Post-extraction bead clean-up lowers inhibition. Overall, 67 % of sequenced samples (Illumina MiSeq) contain <10 % human DNA, with >93 % concordance between WGS-based species and susceptibility predictions and clinical diagnosis. If >60 % of sequencing reads are human (7/98 samples) susceptibility prediction becomes compromised. Novel MinION-based WGS (n=9) currently gives rapid species identification but not susceptibility prediction.

CONCLUSION

Our method for DNA preparation allows WGS-based diagnosis direct from blood culture bottles, providing species and antibiotic susceptibility prediction in a single assay.

摘要

目的

血流感染诊断的速度对于降低发病率和死亡率至关重要。直接从液体血培养物中进行全基因组测序(WGS)可提供单检测物种和抗生素敏感性预测;然而,高抑制剂和人类细胞/DNA浓度限制了病原体的回收。我们开发了一种直接从液体血培养物中制备用于基于WGS诊断的细菌DNA的方法。

方法

我们评估了三种商业DNA提取试剂盒:BiOstic菌血症试剂盒、Amplex Hyplex试剂盒和MolYsis Plus试剂盒。测试了差速离心、过滤、选择性裂解和固相可逆固定磁珠净化,以改善人类细胞/DNA和抑制剂的去除。使用WGS(Illumina/MinION),我们评估了人类DNA的去除、病原体的回收,并对44种革兰氏阴性菌和54种葡萄球菌的阳性血培养物中的物种和抗生素敏感性进行了预测。结果/主要发现。BiOstic试剂盒提取产生的平均DNA浓度最高,为94 - 301 ng/µl,而使用Amplex和MolYsis试剂盒时为0 - 2.5 ng/µl。然而,我们注意到BiOstic提取物中的抑制水平较高(260/280比率为0.9 - 2.1)和人类DNA含量较高(0.0 - 4.4×10 copies)。在BiOstic提取之前进行差速离心(2000 g,1分钟)可使人类DNA减少63 - 89%,选择性裂解可进一步减少62%。提取后磁珠净化降低了抑制作用。总体而言,67%的测序样本(Illumina MiSeq)含有的人类DNA <10%,基于WGS的物种和敏感性预测与临床诊断之间的一致性>93%。如果>60%的测序读数是人类的(7/98个样本),敏感性预测就会受到影响。基于新型MinION的WGS(n = 9)目前可实现快速物种鉴定,但无法进行敏感性预测。

结论

我们的DNA制备方法允许直接从血培养瓶中进行基于WGS的诊断,在一次检测中提供物种和抗生素敏感性预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f7a/5882078/980f4616e603/jmm-67-347-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验